Esomeprazole 20mg gastro-resistant tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant tablets

northstar healthcare unlimited company - esomeprazole - gastro-resistant tablet - 20mg

ESOMEPRAZOLE INOVAMED 20 MG Israel - English - Ministry of Health

esomeprazole inovamed 20 mg

inovamed ltd - esomeprazole as magnesium trihydrate - gastro resistant tablets - esomeprazole as magnesium trihydrate 20 mg - esomeprazole - esomeprazole inovamed tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.esomeprazole inovamed 20 mg tablets are indicated in adolescents from the age of 12 years forgastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophgeal reflux disease (gerd)in combination with antibiotics in treatment of duodenal ulcer caused by helicobactor pylori

ESOMEPRAZOLE INOVAMED 40 MG Israel - English - Ministry of Health

esomeprazole inovamed 40 mg

inovamed ltd - esomeprazole as magnesium trihydrate - gastro resistant tablets - esomeprazole as magnesium trihydrate 40 mg - esomeprazole - esomeprazole inovamed tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.esomeprazole inovamed 40 mg tablets are indicated in adolescents from the age of 12 years for;gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis

ESOMEPRAZOLE TABLET (DELAYED-RELEASE) Canada - English - Health Canada

esomeprazole tablet (delayed-release)

sanis health inc - esomeprazole (esomeprazole magnesium dihydrate) - tablet (delayed-release) - 20mg - esomeprazole (esomeprazole magnesium dihydrate) 20mg

APO-ESOMEPRAZOLE TABLET (DELAYED-RELEASE) Canada - English - Health Canada

apo-esomeprazole tablet (delayed-release)

apotex inc - esomeprazole (esomeprazole magnesium) - tablet (delayed-release) - 20mg - esomeprazole (esomeprazole magnesium) 20mg - proton-pump inhibitors